Invention Application
US20130085142A1 SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS
有权
取代的OCTAHYDROPRROLO [1,2-a]吡啶作为钙通道阻断剂
- Patent Title: SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS
- Patent Title (中): 取代的OCTAHYDROPRROLO [1,2-a]吡啶作为钙通道阻断剂
-
Application No.: US13627541Application Date: 2012-09-26
-
Publication No.: US20130085142A1Publication Date: 2013-04-04
- Inventor: Tao Li , Sachin V. Patel , Richard J. Perner , John T. Randolph , Michael R. Schrimpf , Kevin R. Woller , Zhiren Xia , Qingwei Zhang
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: ABBVIE INC.
- Current Assignee: ABBVIE INC.
- Current Assignee Address: US IL North Chicago
- Main IPC: C07D487/04
- IPC: C07D487/04
![SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS](/abs-image/US/2013/04/04/US20130085142A1/abs.jpg.150x150.jpg)
Abstract:
The present application relates to: (a) compounds of Formula (I): and salts thereof, wherein Z1, Z2, Z3, Z4, R1, R2, and R3 are as defined in the specification; (b) compositions comprising such compounds and salts; and (c) methods of use of such compounds, salts, and compositions, particularly use as calcium channel inhibitors.
Public/Granted literature
- US08669255B2 Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers Public/Granted day:2014-03-11
Information query